CXS chemgenex pharmaceuticals ltd
Add to My Watchlist 0.00% ! 70.0¢

chemgenex at international conference

  1. diersel
    445 Posts.
    lightbulb Created with Sketch. 7
    clock Created with Sketch.
    11/11/10
    10:41
    Post #: 7459557
    Results combined from chemgenex study 202 and 203 (multi TKI failure) will be presented at the American Society of Hematology Conference in Florida on 5th December, 2010.

    "Subcutaneous Omacetaxine (OM) Treatment of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients Following Multiple Tyrosine Kinase Inhibitor (TKI) Failure"


    You can read the abstract of the presentation at this link:

    http://ash.confex.com/ash/2010/webprogram/Paper31550.html
    CXS Price at posting: 49.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Vulcan signs first major Phase One contract with NESI
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 023 – Glowing gold, shining silver, and... wheat collusion?
right-arrow Created with Sketch.
NEWS Stay ahead - view the latest ASX market news
right-arrow Created with Sketch.
NEWS Rubix advances proposed acquisition of prospective Bauxite Projects in Africa
right-arrow Created with Sketch.
NEWS Marquee confirms high-grade antimony ahead of maiden JORC resource
right-arrow Created with Sketch.
NEWS Arrowsmith North Silica Sand Project granted works approval
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.